Beijing Kawin Technology Share-Holding Co., Ltd.

Shanghai Stock Exchange 688687.SS

Beijing Kawin Technology Share-Holding Co., Ltd. Goodwill for the year ending December 31, 2023: USD 0.00

Beijing Kawin Technology Share-Holding Co., Ltd. Goodwill is USD 0.00 for the year ending December 31, 2023, a 0.00% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.
  • Beijing Kawin Technology Share-Holding Co., Ltd. Goodwill for the year ending December 31, 2022 was USD 0.00, a 0.00% change year over year.
  • Beijing Kawin Technology Share-Holding Co., Ltd. Goodwill for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
  • Beijing Kawin Technology Share-Holding Co., Ltd. Goodwill for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
  • Beijing Kawin Technology Share-Holding Co., Ltd. Goodwill for the year ending December 31, 2019 was USD 0.00, a 0.00% change year over year.
Key data
Date Goodwill Total Assets Current Liabilities Total Non-Current Liabilities
Market news
SV Wall Street
Shanghai Stock Exchange: 688687.SS

Beijing Kawin Technology Share-Holding Co., Ltd.

CEO Mr. Desheng Zhou
IPO Date Feb. 8, 2021
Location China
Headquarters Building 3, No. 6, Rongjing East Street
Employees 584
Sector Healthcare
Industries
Biotechnology Clinical Trials Cosmetics Non-Alcoholic Beverages Personal Care Pharmaceuticals Plastics Vaccines
Description

Beijing Kawin Technology Share-Holding Co., Ltd. engages in the development and production of pharmaceutical products primarily in the areas of liver diseases in China. The company's products include recombinant human interferon alfa-2b injection and compound glycyrrhizin. It provides active pharmaceutical ingredients; clinical research services for biological product development, which include drug substances–fermentation and purification, drug product–formulation, and analytical methods development; and contract manufacturing services. The company also serves customers in Pakistan, Colombia, Philippines, Vietnam, Russia, Cambodia, and others. It has strategic partnership with Legend Capital, Haitong Capital, and Cybernaut. The company was founded in 2008 and is based in Beijing, China.

Similar companies

688670.SS

Jiangsu gdk Biotechnology Co., Ltd.

USD 1.59

-1.04%

StockViz Staff

February 2, 2025

Any question? Send us an email